Tang Capital Management as of June 30, 2021
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 16 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 24.4 | $123M | 7.9M | 15.52 | |
| Rocket Pharmaceuticals (RCKT) | 22.3 | $112M | 2.5M | 44.29 | |
| Anaptysbio Inc Common (ANAB) | 13.6 | $68M | 2.6M | 25.93 | |
| Odonate Therapeutics Ord | 10.8 | $54M | 16M | 3.49 | |
| La Jolla Pharmaceuticl Com Par | 8.6 | $43M | 10M | 4.28 | |
| Aptevo Therapeutics Com New | 7.9 | $40M | 1.8M | 22.43 | |
| Vincerx Pharma Com New (VINC) | 2.7 | $13M | 1.0M | 12.99 | |
| Coherus Biosciences (CHRS) | 1.8 | $9.0M | 650k | 13.83 | |
| Altimmune Com New (ALT) | 1.5 | $7.7M | 783k | 9.85 | |
| Chemocentryx | 1.3 | $6.7M | 500k | 13.39 | |
| Reviva Pharmaceutcls Hldgs I (RVPH) | 1.2 | $5.8M | 1.2M | 4.86 | |
| Iteos Therapeutics (ITOS) | 1.1 | $5.6M | 219k | 25.65 | |
| Bctg Acquisition Corp | 1.1 | $5.3M | 469k | 11.38 | |
| Equillium (EQ) | 0.7 | $3.5M | 600k | 5.89 | |
| Relmada Therapeutics (RLMD) | 0.6 | $3.2M | 100k | 32.01 | |
| Nextcure (NXTC) | 0.5 | $2.4M | 300k | 8.03 |
